| Identification | Back Directory | [Name]
Benzenesulfonamide, 4-[[7'-[(1R,2S)-2-hydroxy-2-methylcyclopentyl]-6'-oxospiro[cyclopropane-1,5'-[5H]pyrrolo[2,3-d]pyrimidine]-2'(7'H)-yl]amino]-N-(3-methyl-3-azetidinyl)-, rel- | [CAS]
2498658-13-0 | [Synonyms]
CDK2-IN-7 Benzenesulfonamide, 4-[[7'-[(1R,2S)-2-hydroxy-2-methylcyclopentyl]-6'-oxospiro[cyclopropane-1,5'-[5H]pyrrolo[2,3-d]pyrimidine]-2'(7'H)-yl]amino]-N-(3-methyl-3-azetidinyl)-, rel- | [Molecular Formula]
C24H30N6O4S | [MOL File]
2498658-13-0.mol | [Molecular Weight]
498.6 |
| Hazard Information | Back Directory | [Uses]
CDK2-IN-7 is a CDK2 inhibitor for researching cancer (IC50 < 50 nM). | [IC 50]
CDK2/cyclinE: 50 nM (IC50) | [References]
[1] Sabnis RW. Sulfonylamide Compounds as CDK2 Inhibitors for Treating Cancer. ACS Med Chem Lett. 2021 Sep 13;12(10):1528-1529. DOI:10.1021/acsmedchemlett.1c00471 |
|
|